The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Represented financial institution in fair lending investigation
Advised a federally-chartered financial institution in connection with a fair lending investigation initiated by the OCC and referred to the more
Real estate and construction consultation to Kane Realty on a continuing care retirement community project
Represented Kane Realty as a joint venture partner involved in the development and construction of a continuing care retirement community (CCRC), more
Patent prosecution and portfolio management for Emory University
Represent Emory University in connection with the provision of patent prosecution and portfolio management services in the areas of psychiatry, more
Environmental issues related to disposition and ownership of major Atlanta-area landowner's properties
Represent a major Atlanta-area landowner with all of the environmental matters related to ownership and disposition of properties.  We manage more